Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation
Molecules · 2024
DOI: 10.3390/molecules29102345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Lingna Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Acne Vulgaris, Glycyrrhetinic Acid, Molecular Docking Simulation, Network Pharmacology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Rejuvenation of Science and Technology for Mongolia, Research and Development Program of Guangdong Province.
Abstract (Originalsprache)
Glycyrrhetinic acid (GA) is a saponin compound, isolated from licorice (Glycyrrhiza glabra), which has been wildly explored for its intriguing pharmacological and medicinal effects. GA is a triterpenoid glycoside displaying an array of pharmacological and biological activities, including anti-inflammatory, anti-bacterial, antiviral and antioxidative properties. In this study, we investigated the underlying mechanisms of GA on acne vulgaris through network pharmacology and proteomics. After the intersection of the 154 drug targets and 581 disease targets, 37 therapeutic targets for GA against acne were obtained. A protein–protein interaction (PPI) network analysis highlighted TNF, IL1B, IL6, ESR1, PPARG, NFKB1, STAT3 and TLR4 as key targets of GA against acne, which is further verified by molecular docking. The experimental results showed that GA inhibited lipid synthesis in vitro and in vivo, improved the histopathological damage of skin, prevented mast cell infiltration and decreased the level of pro-inflammatory cytokines, including TNF-α, IL-1β and IL-6. This study indicates that GA may regulate multiple pathways to improve acne symptoms, and the beneficial effects of GA against acne vulgaris might be through the regulation of sebogenesis and inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
- Shenzhen Liran Cosmetics Co., Ltd., Shenzhen 518000, China.
- Chemistry of RNA, Nucleosides, Peptides and Heterocycles, CNRS UMR8601, Université Paris Cité, 45 Rue des Saints-Pères, CEDEX 06, 75270 Paris, France.
- Foshan Allan Conney Biotechnology Co., Ltd., Foshan 528231, China.
ORCID-Profile: Lingna Xie
Förderung
- National Natural Science Foundation of China
- Project of Rejuvenation of Science and Technology for Mongolia
- Research and Development Program of Guangdong Province
Zitieren
APA
Xie, L., Ma, C., Li, X., Chen, H., Han, P., Lin, L., Huang, W., Xu, M., Lu, H., & Du, Z. (2024). Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation. Molecules. https://doi.org/10.3390/molecules29102345
Vancouver
Xie L, Ma C, Li X, Chen H, Han P, Lin L, et al. Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation. Molecules. 2024. doi:10.3390/molecules29102345
BibTeX
@article{Xie2024,
author = {Xie, Lingna and Ma, Congwei and Li, Xinyu and Chen, Huixiong and Han, Ping and Lin, Li and Huang, Weiqiang and Xu, Menglu and Lu, Hailiang and Du, Zhiyun},
title = {Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102345}
}
EUVIMED